- freely available
Targeted Delivery of Protein Drugs by Nanocarriers
AbstractRecent advances in biotechnology demonstrate that peptides and proteins are the basis of a new generation of drugs. However, the transportation of protein drugs in the body is limited by their high molecular weight, which prevents the crossing of tissue barriers, and by their short lifetime due to immuno response and enzymatic degradation. Moreover, the ability to selectively deliver drugs to target organs, tissues or cells is a major challenge in the treatment of several human diseases, including cancer. Indeed, targeted delivery can be much more efficient than systemic application, while improving bioavailability and limiting undesirable side effects. This review describes how the use of targeted nanocarriers such as nanoparticles and liposomes can improve the pharmacokinetic properties of protein drugs, thus increasing their safety and maximizing the therapeutic effect.
Share & Cite This Article
Export to BibTeX | EndNote
MDPI and ACS Style
Solaro, R.; Chiellini, F.; Battisti, A. Targeted Delivery of Protein Drugs by Nanocarriers. Materials 2010, 3, 1928-1980.View more citation formats
Solaro R, Chiellini F, Battisti A. Targeted Delivery of Protein Drugs by Nanocarriers. Materials. 2010; 3(3):1928-1980.Chicago/Turabian Style
Solaro, Roberto; Chiellini, Federica; Battisti, Antonella. 2010. "Targeted Delivery of Protein Drugs by Nanocarriers." Materials 3, no. 3: 1928-1980.